Physician profile
Amy E Perez
NPI 1235597808
$1,160.05
in general payments reported to CMS, 2019-2025
12 companies · $354 in 2025
The $354 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $74.50 · 2022: $238 · 2023: $476 · 2024: $17.11 · 2025: $354.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $848.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $847.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $336.16 | 2022-2023 | |
| Cvrx, INC. | $189.22 | 2023 | Barostim Neo System |
| Abbott Laboratories | $168.07 | 2025 | Amplatzer Amulet |
| Genentech USA, INC. | $123.41 | 2022 | |
| Axsome Therapeutics, INC. | $122.46 | 2025 | Symbravo |
| E.R. Squibb & Sons, L.L.C. | $74.50 | 2021 | |
| Novo Nordisk INC | $40.07 | 2025 | Wegovy |
| Grt US Holding, INC. | $25.43 | 2022 | |
| Mdd US Operations, LLC | $23.81 | 2025 | Qelbree |
| Allergan, INC. | $21.31 | 2022 | |
| Eisai INC. | $18.50 | 2022 | |
| Amneal Pharmaceuticals LLC | $17.11 | 2024 | Rytary |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Perez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.